Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Change in Intangibles (2019 - 2025)

Historic Change in Intangibles for Pharma (IGC) over the last 7 years, with Q3 2025 value amounting to $297000.0.

  • Pharma's Change in Intangibles rose 47115.38% to $297000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $636000.0, marking a year-over-year increase of 3417.72%. This contributed to the annual value of $370000.0 for FY2025, which is 185.68% down from last year.
  • Latest data reveals that Pharma reported Change in Intangibles of $297000.0 as of Q3 2025, which was up 47115.38% from $114000.0 recorded in Q2 2025.
  • In the past 5 years, Pharma's Change in Intangibles ranged from a high of $498000.0 in Q1 2022 and a low of $2000.0 during Q2 2021
  • In the last 5 years, Pharma's Change in Intangibles had a median value of $52000.0 in 2024 and averaged $106947.4.
  • In the last 5 years, Pharma's Change in Intangibles crashed by 9230.77% in 2021 and then surged by 156000.0% in 2022.
  • Pharma's Change in Intangibles (Quarter) stood at $22000.0 in 2021, then soared by 281.82% to $84000.0 in 2022, then plummeted by 77.38% to $19000.0 in 2023, then soared by 305.26% to $77000.0 in 2024, then surged by 285.71% to $297000.0 in 2025.
  • Its Change in Intangibles stands at $297000.0 for Q3 2025, versus $114000.0 for Q2 2025 and $148000.0 for Q1 2025.